International Medical Center

Chang Gung Memorial Hospital, Linkou, Garners Two Prestigious International Awards for Its Outstanding Achievements

Retrieved on: 
星期二, 四月 30, 2024
Investment, International Medical Center, Hospital, AI, Proton therapy, Bed, Internal medicine, Pediatrics, Lymphedema, EMRAM, Research, Organ transplantation, Patient safety, Gynaecology, Accreditation, HIMSS, Patient, JCI, Health, Multimedia, Patient satisfaction, Medicine, Nursing

TAOYUAN, April 29, 2024 /PRNewswire/ -- The Healthcare Asia Awards, a prestigious international recognition program, honors exceptional healthcare institutions across Asia for their pioneering achievements in healthcare innovation and patient care. On March 26th, at the 2024 Awards Ceremony held in Singapore, Chang Gung Memorial Hospital, Linkou, Taiwan, emerged victorious, capturing the coveted titles of Hospital of the Year - Taiwan and Smart Hospital Initiative of the Year - Taiwan.

Key Points: 
  • With over 30 departments, Chang Gung Memorial Hospital offers a broad spectrum of services, including internal medicine, surgery, gynecology, and pediatrics.
  • Chang Gung Memorial Hospital not only excels in medical technology and services but also prioritizes patient safety and compassionate care.
  • This year, the Healthcare Asia Awards acknowledged Chang Gung Memorial Hospital in Linkou for its exceptional leadership in medical services, research, and smart healthcare innovations.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/chang-gung-memorial-hospital-li...
    SOURCE Chang Gung Memorial Hospital, Linkou

Saitama Medical University International Medical Center Selects MRIdian® MRI-Guided Radiation Therapy System

Retrieved on: 
星期二, 七月 19, 2022
Research, SEC, Nausea, Lung, Accrediting Commission International, SBRT, Toxic leukoencephalopathy, Cancer, Patient, Neoplasm, Security (finance), JCI, Hospital, Nasdaq, U.S. Securities and Exchange Commission, Safety, Department, Prostate, Skin, Private Securities Litigation Reform Act, Technology, Radiation therapy, MRI, NCI-designated Cancer Center, International Medical Center, Saitama Medical University, Certification, Fatigue, Magnetic resonance imaging, NASDAQ, Medical school, Physician, Industry, COVID-19, Liver, Company, Irritation, Hair loss, Pancreas, Breast, Joint Commission, Patient safety, Annual report, 2021 Essex County Council election, Radiation, Toxicity, Field line, Medical imaging

CLEVELAND, July 19, 2022 /PRNewswire/ --ViewRay, Inc. (NASDAQ: VRAY) today announced that Saitama Medical University International Medical Center has purchased a MRIdian MRI-Guided Radiation Therapy System to complete its newly built comprehensive cancer center in Yamane, Hidaka-City.

Key Points: 
  • CLEVELAND, July 19, 2022 /PRNewswire/ --ViewRay, Inc. (NASDAQ: VRAY) today announced that Saitama Medical University International Medical Center has purchased a MRIdian MRI-Guided Radiation Therapy System to complete its newly built comprehensive cancer center in Yamane, Hidaka-City.
  • The MRIdian system will enable Saitama Medical University to offer advanced MRI-guided radiation therapy technology to cancer patients who are seeking personalized treatment for pancreas, prostate, lung, liver, breast, and oligometastaticcancers.
  • Saitama Medical University International Medical Center is slated to install its MRIdian system in December 2022, with the first patient treatments beginning in early 2023.
  • In February 2015 Saitama Medical University International Medical Center became the first university hospital in Japan to acquire Joint Commission International (JCI) certification, demonstrating its adherence to international quality standards for medical quality and safety.

Worldwide Bioprosthetic Heart Valves Industry to 2028 - by Type, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
星期五, 七月 8, 2022
Health, Cardiology, American College of Cardiology, Aortic valve, Trifecta, Patient, Lists of countries and territories, Research, CVD, Adoption, International Medical Center, Boston Scientific, Femoral artery, Growth, St. Jude Medical, Edwards Lifesciences, Prevalence, Abbott Laboratories, CAGR, MHLW, Degenerative disease, Catheter, Incidence, Government, Aeson, Hospital, Medical device, Medical imaging, Marketing, Health

The global bioprosthetic heart valves market is anticipated to grow at a substantial CAGR of 11.4% during the forecast period.

Key Points: 
  • The global bioprosthetic heart valves market is anticipated to grow at a substantial CAGR of 11.4% during the forecast period.
  • The global bioprosthetic heart valves market is segmented based on the type, and end-user.
  • Analysis of regional regulations and other government policies impacting the global bioprosthetic heart valves market.
  • Insights about market determinants that are stimulating the global bioprosthetic heart valves market.

IMC Health Now Offering Pain Management

Retrieved on: 
星期五, 十月 18, 2019
Other Health, Hospitals, Health, Physical therapy, Managed care, Specialty, Summit Medical Group, International Medical Center

The new services will be branded as IMC Health Pain Management & Arthritis Centers.

Key Points: 
  • The new services will be branded as IMC Health Pain Management & Arthritis Centers.
  • "We are very excited to be able to offer this service to our members who meet the medical criteria for pain management.
  • Many of our patients are senior citizens and suffer from joint pain and arthritis," said William C. Lamoreaux, Chief Executive Officer of IMC.
  • IMC Medical Centers now offers a comprehensive set of specialty services including pain management, dental, neurology, cardiology, pulmonology, gastroenterology, radiology, dermatology, optometry, womens wellness and podiatry services.